Pre-event Media release of Pharmasafe India 2017


Messe Frankfurt is organizing  3rd edition of Pharmasafe India 2017 at Mumbai. This conference is on 14th and 15th September. As the Indian pharmaceutical industry, growing at an annual CAGR of around 15% is constantly evolving and investing in R&D to become an ever more formidable player globally, counterfeiting remains an ever increasing challenge. Pharmaceutical counterfeiting is multi-billion-dollar enterprise globally resulting in huge revenue loss to pharmaceutical companies, while at the same time posing grave health risks to the patient which diminishes confidence in the brand, estimated 1 out of 5 drugs sold in India and in the developing world are counterfeit is itself a wakeup call. It will be comprising of 6 sessions for both of the days. The that will be covered under this conference are  Counterfieting issues in Indian marketplace along with national drug survey report. Other topics to be covered under this conference are Countering pharmaceutical counterfeiting through collective action, Solutions for pharmaceutical anti-counterfeiting – capsules/tablets, Combating drug counterfeiting using mobile and web technologies, Pharmaceutical anti-counterfeiting investigations, Packaging authentication solutions, Future of pharma safety: Role of e-commerce. Prominient speakers for this conference are Dr K Bangarurajan, Deputy Drugs Controller, West Zone CDSCO, Mr Biswajit Das, HOB Economic Offense Wing CBI, Mr Stephen Dunn, Regional Director of Investigation Asia Pacific, Sanofi Aventis Singapore, and few others.

Pharmasafe India will bring together over 150 delegates and speakers representing cross-section of stakeholders –business leaders from top pharmaceutical companies, eminent experts in anti-counterfeiting technology, government & regulatory authorities, customs, investigators, legal experts, consultants and leading industry bodies to share a common platform for discussions, The conference is at Holiday Inn, Mumbai. Sci Journo- InClinition’s Science Journal is the official media partner for the conference.

You might also like More from author